Is EMR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMR (CHF64.57) is trading below our estimate of fair value (CHF69.57)
Significantly Below Fair Value: EMR is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMR?
Key metric: As EMR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for EMR. This is calculated by dividing EMR's market cap by their current
earnings.
What is EMR's PE Ratio?
PE Ratio
46x
Earnings
US$1.62b
Market Cap
US$74.49b
EMR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: EMR is expensive based on its Price-To-Earnings Ratio (46x) compared to the European Electrical industry average (16.3x).
Price to Earnings Ratio vs Fair Ratio
What is EMR's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
EMR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
46x
Fair PE Ratio
34.8x
Price-To-Earnings vs Fair Ratio: EMR is expensive based on its Price-To-Earnings Ratio (46x) compared to the estimated Fair Price-To-Earnings Ratio (34.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst EMR forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
CHF 64.57
CHF 119.10
+84.4%
9.3%
CHF 137.13
CHF 92.89
n/a
26
Nov ’25
CHF 64.57
CHF 109.20
+69.1%
9.2%
CHF 132.33
CHF 89.08
n/a
24
Oct ’25
CHF 64.57
CHF 107.02
+65.7%
8.7%
CHF 129.47
CHF 87.16
n/a
24
Sep ’25
CHF 64.57
CHF 111.06
+72.0%
7.9%
CHF 132.40
CHF 89.13
n/a
23
Aug ’25
CHF 64.57
CHF 117.84
+82.5%
6.7%
CHF 137.05
CHF 98.53
n/a
23
Jul ’25
CHF 64.57
CHF 117.30
+81.7%
5.9%
CHF 125.62
CHF 98.70
n/a
22
Jun ’25
CHF 64.57
CHF 118.54
+83.6%
6.5%
CHF 127.89
CHF 100.49
n/a
22
May ’25
CHF 64.57
CHF 113.07
+75.1%
6.7%
CHF 126.52
CHF 95.58
n/a
23
Apr ’25
CHF 64.57
CHF 108.45
+68.0%
6.8%
CHF 120.85
CHF 85.67
n/a
24
Mar ’25
CHF 64.57
CHF 103.36
+60.1%
8.4%
CHF 118.08
CHF 83.71
n/a
23
Feb ’25
CHF 64.57
CHF 95.63
+48.1%
9.4%
CHF 116.68
CHF 76.62
n/a
23
Jan ’25
CHF 64.57
CHF 92.32
+43.0%
9.3%
CHF 107.59
CHF 75.74
n/a
23
Dec ’24
CHF 64.57
CHF 94.06
+45.7%
9.0%
CHF 110.47
CHF 77.77
n/a
23
Nov ’24
CHF 64.57
CHF 98.94
+53.2%
7.5%
CHF 112.39
CHF 85.42
CHF 64.57
23
Oct ’24
CHF 64.57
CHF 100.66
+55.9%
7.2%
CHF 112.35
CHF 87.49
CHF 64.57
23
Sep ’24
CHF 64.57
CHF 95.09
+47.3%
8.1%
CHF 107.81
CHF 79.53
CHF 64.57
23
Aug ’24
CHF 64.57
CHF 90.81
+40.6%
9.8%
CHF 107.33
CHF 73.02
CHF 64.57
22
Jul ’24
CHF 64.57
CHF 92.25
+42.9%
9.7%
CHF 109.41
CHF 74.43
CHF 64.57
22
Jun ’24
CHF 64.57
CHF 92.67
+43.5%
10.7%
CHF 111.13
CHF 71.96
CHF 64.57
23
May ’24
CHF 64.57
CHF 91.69
+42.0%
10.4%
CHF 109.04
CHF 70.61
CHF 64.57
22
Apr ’24
CHF 64.57
CHF 93.71
+45.1%
11.1%
CHF 112.57
CHF 72.89
CHF 64.57
20
Mar ’24
CHF 64.57
CHF 94.08
+45.7%
11.1%
CHF 112.79
CHF 73.04
CHF 64.57
20
Feb ’24
CHF 64.57
CHF 94.40
+46.2%
11.2%
CHF 111.85
CHF 72.43
CHF 64.57
20
Jan ’24
CHF 64.57
CHF 97.63
+51.2%
11.8%
CHF 116.10
CHF 73.38
CHF 64.57
21
Dec ’23
CHF 64.57
CHF 97.99
+51.8%
12.2%
CHF 118.29
CHF 74.76
CHF 64.57
20
Nov ’23
CHF 64.57
CHF 101.21
+56.7%
12.4%
CHF 125.02
CHF 79.01
CHF 64.57
20
Analyst Forecast: Target price is less than 20% higher than the current share price.